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Summary
Intercellular signaling molecules and their receptors,
whose expression must be tightly regulated in time
and space, coordinate organogenesis. Regulators of
intracellular signaling pathways provide an additional
level of control. Here we report that loss of the recep-
tor tyrosine kinase (RTK) antagonist, Sprouty1 (Spry1),
causes defects in kidney development in mice.
Spry1−/− embryos have supernumerary ureteric buds,
resulting in the development of multiple ureters and
multiplex kidneys. These defects are due to increased
sensitivity of the Wolffian duct to GDNF/RET signal-
ing, and reducing Gdnf gene dosage correspondingly
rescues the Spry1 null phenotype. We conclude that
the function of Spry1 is to modulate GDNF/RET sig-
naling in the Wolffian duct, ensuring that kidney in-
duction is restricted to a single site. These results
demonstrate the importance of negative feedback
regulation of RTK signaling during kidney induction
and suggest that failures in feedback control may un-
derlie some human congenital kidney malformations.*Correspondence: albert.basson@kcl.ac.uk (M.A.B.); jonathan.
licht@mssm.edu (J.D.L.)
7 Present address: INSERM U381, 3 Avenue Molière, 67000 Stras-
bourg, France.Introduction
It has become clear that many steps in mammalian de-
velopment depend not only on mediators of intercellu-
lar signaling but also on molecules that negatively regu-
late this signaling. For example, mutations in genes
encoding antagonists of the TGFβ and WNT pathways,
which play major roles in mammalian embryogenesis,
often result in developmental defects (Bachiller et al.,
2000; Matzuk et al., 1995; Mukhopadhyay et al., 2001;
Perea-Gomez et al., 2002; Zuniga et al., 1999). There is
accumulating evidence that inhibitors of receptor tyro-
sine kinase (RTK) signaling also play important roles
during organogenesis (Freeman, 2000).
Studies in Drosophila identified the sprouty (spry)
gene as a negative feedback regulator of branching
morphogenesis of the tracheal system (Hacohen et al.,
1998), compound eye development (Casci et al., 1999),
and other developmental processes (Kramer et al.,
1999; Reich et al., 1999) mediated by Fibroblast Growth
Factor (FGF) and other RTK signaling pathways. Four
vertebrate orthologs of the Drosophila spry gene have
been identified. Both loss- and gain-of-function experi-
ments in mouse (Chi et al., 2004; Minowada et al.,
1999), chicken (Chambers et al., 2000), zebrafish
(Furthauer et al., 2001), and Xenopus (Nutt et al., 2001)
embryos indicate that RTK signaling, at least via the
FGF pathway, is both necessary and sufficient for
Sprouty gene expression.
Misexpression or overexpression studies of Sprouty
genes in zebrafish (Furthauer et al., 2001), frog (Nutt et
al., 2001), chick (Minowada et al., 1999), and mouse
(Chi et al., 2004; Lee et al., 2001; Mailleux et al., 2001;
Perl et al., 2003; Tefft et al., 1999) embryos or tissues
suggested that these genes play important roles in ver-
tebrate development. However, there have been few
loss-of-function experiments to directly test this hy-
pothesis, including gene knockdown studies in zebra-
fish embryos (Furthauer et al., 2001) and mouse lung
and kidney explants (Gross et al., 2003; Tefft et al.,
1999). Here we describe the production of a Spry1 null
allele in the mouse and demonstrate that Spry1 is
essential for normal kidney development.
The first morphologically discernable step of kidney
development in the mouse is the outgrowth of the ure-
teric bud (UB) from the caudal Wolffian duct at E11
(Saxen, 1987). Formation of the UB, which develops
into the collecting system of the kidney, is induced by
glial cell line-derived neurotrophic factor (GDNF). GDNF
is produced by the metanephric mesenchyme and acti-
vates a RTK (RET)/coreceptor (GFRα1) complex on the
Wolffian duct epithelium, resulting in UB outgrowth
(Vainio and Lin, 2002). Accordingly, Gdnf, Ret, or Gfra1
null embryos exhibit renal agenesis due to failure of UB
formation (Cacalano et al., 1998; Moore et al., 1996;
Pachnis et al., 1993; Pichel et al., 1996; Sanchez et al.,
1996).
Gdnf expression is under tight spatiotemporal control
during development. Prior to kidney induction, Gdnf is
expressed along the anterior-posterior length of the
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tforms (40 somite stage), Gdnf expression is restricted
Sto the posterior mesenchyme adjacent to the presump-
ctive site of UB outgrowth (Grieshammer et al., 2004).
lMutations that allow Gdnf expression to be maintained
3in the anterior nephrogenic mesenchyme result in su-
tpernumerary UBs and the formation of multiplex kid-
aneys with multiple abnormal ureters that often fail to
sconnect properly to the bladder (Grieshammer et al.,
2004; Kume et al., 2000). This condition resembles the
thuman syndrome of congenital anomalies of the kidney
Sand urinary tract (CAKUT) that occur in about 1/200
tpregnancies (Ichikawa et al., 2002).
TIn the present study, we show that Spry1 inhibits the
mresponsiveness of the Wolffian duct to GDNF signaling,
rthus ensuring the formation of a single UB during in-
mduction of the metanephric kidney.
a
dResults
r
3Spry1−/− Mice Exhibit Kidney and Urinary
UTract Anomalies
aUsing Cre/lox technology, we produced mouse lines
mcarrying a conditional (Spry1flox) allele in which the
dSpry1 open reading frame was flanked with loxP sites
and a null (Spry1−) allele in which the entire coding se-
uquence was deleted (Figure 1). Mice homozygous for
othe Spry1flox allele or heterozygous for the null allele
i(Spry1+/−) were viable, fertile, and appeared phenotypi-
Scally normal.
tHomozygous Spry1−/− mice were born at the ex-
apected Mendelian ratios, but viability after birth was re-
dduced. Of 38 pups born, 8 (21%) died within 48 hr and
d27 (71%) died within 5 months. Of 21 Spry1−/− animals
pexamined shortly after birth, 20 displayed uni- or bilat-
(eral ureter (multiple ureters, hydroureter) and kidney
malformations (Figure 2). Abnormal ureters ended Sblindly in females (Figures 2A and 2B) and were at- btached to the vas deferens in males (Figures 2C–2F).
THistological analyses revealed disorganized kidneys in
ewhich the nephrogenic zones were not restricted to the
v
cortex as in normal newborn kidneys (Figure 2G) but
l
extended throughout the kidney (Figure 2H), suggesting
p
that what appeared macroscopically as a single unit a
was actually several kidney primordia fused together. a
The mutant kidneys frequently contained multiple epi- p
thelial cysts (Figure 2H) that stained strongly with dol- s
ichus biflorus agglutinin (DBA) lectin (Figure 2I), indicat- H
ing that they were derived from the collecting system e
of the kidney (Qiao et al., 1995). These phenotypes are e
characteristic of human CAKUT (Ichikawa et al., 2002). t
Although the genetic causes of CAKUT are not known, 1
abnormalities during the initial phases of kidney induc- e
tion were suggested as the likely underlying cause p
(Ichikawa et al., 2002). We therefore analyzed early kid- d
ney development in Spry1−/− embryos. G
p
Urinary Tract Defects in Spry1−/− Animals Result t
from Supernumerary Ureteric Bud Formation
We assessed Wolffian duct and UB morphology in S
E11.0–E11.5 embryos by in situ hybridization for Ret C
(Kume et al., 2000; Pachnis et al., 1993). Spry1−/− em- W
bryos exhibited abnormally wide UBs compared to A
stage-matched controls at E11.0 (Figures 3A and 3B),nd supernumerary buds were evident along the mu-
ant duct (Figure 3B). By E11.5, the normal UB in
pry1+/− embryos demonstrated two branched tips
onnected by a narrow stalk to the Wolffian duct at the
evel of the posterior edge of the hindlimb bud (Figure
C). In contrast, the UB that formed at the normal posi-
ion in Spry1−/− embryos had an abnormally wide stalk
nd tips (Figure 3D). In addition, ectopic UBs were ob-
erved anterior to this wide UB (Figure 3D).
To visualize subsequent branching morphogenesis of
he UBs, E11.5 kidney rudiments were cultured in vitro.
pry1+/− UBs underwent regular, reiterative branching
o give rise to a characteristic ureteric tree (Figure 3E).
he UB tips induced condensation of the metanephric
esenchyme, indicated by PAX2-positive cells sur-
ounding the bud tips (Figure 3E). By contrast, some
utant kidneys demonstrated multiple ureteric stalks
ttached to the Wolffian duct, each of which had un-
ergone branching morphogenesis that resulted in ir-
egular, wide, and occasionally fused UB tips (Figure
F). PAX2 expression was evident around most of the
B tips in Spry1−/− explants (Figure 3F), indicating that
lthough the architecture of Spry1−/− UBs was abnor-
al, they qualitatively retained the capacity to initiate
ifferentiation of the metanephric mesenchyme.
Between E12.5 and E14.5, normal developing ureters
ndergo a maturation process during which the base
f the ureter disconnects from the Wolffian duct and
nserts into the bladder (Batourina et al., 2002). In E14.5
pry1−/− embryos, the supernumerary, abnormal ure-
ers remained attached to the Wolffian duct (Figures 3G
nd 3H). Since the anterior portion of the Wolffian duct
evelops into the vas deferens in male embryos and
egenerates in female embryos, these observations ex-
lain the ureter anomalies in Spry1−/− newborn animals
Figure 2).
pry1 Expression in the Wolffian Duct Is Regulated
y GDNF/RET Signaling
o understand how Spry1 regulates UB formation, we
xamined Spry1 expression at the onset of kidney de-
elopment. At E11.0, Spry1 was detected along the
ength of the Wolffian duct with highest levels in the
osterior duct, where the UB forms. Spry1 RNA was
lso detected in the nephrogenic mesenchyme, albeit
t a significantly lower level (Figure 4A). Since the ex-
ression of Sprouty genes is generally induced by the
ignaling pathways they inhibit (Chambers et al., 2000;
acohen et al., 1998; Mailleux et al., 2001; Minowada
t al., 1999; Nutt et al., 2001; Ozaki et al., 2001; Reich
t al., 1999), and UB formation is induced by the activa-
ion of RET by GDNF (Moore et al., 1996; Pichel et al.,
996; Sanchez et al., 1996), we asked whether Spry1
xpression is dependent upon RET activity. Spry1 ex-
ression was significantly reduced in Ret−/− Wolffian
ucts (Figure 4B), and beads soaked in recombinant
DNF and implanted into intermediate mesoderm ex-
lants rapidly upregulated Spry1 gene expression in
he Wolffian duct (Figures 4C and 4D).
pry1 Is Not Necessary for Normal Spatiotemporal
ontrol of Gdnf Expression but Is Required in the
olffian Duct to Regulate Ureteric Bud Formation
nalysis of other mouse mutants had indicated that su-pernumerary UBs can develop due to the abnormal
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231Figure 1. Generation of Conditional and Null
Spry1 Alleles in Mice
(A) Schematic representation of the Spry1
wild-type allele, the targeting construct, and
the Spry1floxneo allele produced by homolo-
gous recombination at the Spry1 locus in ES
cells. A horizontal line represents Spry1 ge-
nomic DNA; the purple box represents the
Spry1 open reading frame (ORF), which is
contained within one of the three exons
(open boxes). The complete Spry1 ORF was
flanked with loxP sites (red triangles), and a
PGKneo cassette flanked by frt sites (open
blue triangles) was introduced 3# of the
gene. The PGKneo cassette was removed by
breeding mice carrying Spry1floxneo with
b-Actin/Flpe deleter mice (Rodriguez et al.,
2000) to generate a Spry1flox allele. Spry flox/+
animals were bred with b-Actin/Cre deleter
mice to produce animals with Spry1 null al-
lele. B, BglII; E, EcoRI; S, SpeI; X, XbaI.
(B) ES cell clones containing the targeted al-
lele (Spry1floxneo) were identified by Southern
blot using a probe containing sequences 5#
of those used in the targeting vector (black
bar). Results are shown for two independent
clones heterozygous for the targeted allele
and a wild-type clone.
(C) Mice were genotyped by PCR using
primers (P1, P2, P3) located at the positions
shown above the diagram of the wild-type
allele.
(D) RT-PCR assay of RNA extracted from
newborn Spry1+/− and Spry1−/− kidneys using
primer pairs specific for Spry1 or Spry2 cod-
ing sequences. Note that Spry1-encoding
RNA is not detected in Spry1−/− mice,
whereas Spry2-encoding RNA is present. +
or −RT indicates the presence or absence of
reverse transcriptase in the reaction as a
control for genomic DNA contamination.persistence of Gdnf expression in the anterior mes-
enchyme (Grieshammer et al., 2004; Kume et al., 2000).
However, careful examination of Spry1−/− embryos at
the time of bud induction revealed no such anterior
maintenance of Gdnf expression (Figures 4E and 4F).
Therefore, a more likely explanation for the UB defects
in Spry1−/− animals is that Spry1 functions in the Wolff-
ian duct to regulate signaling downstream of RET. To
determine whether Spry1 acts primarily in the Wolffian
duct during kidney development, we specifically de-
leted Spry1 in the duct by crossing mice carrying a con-
ditional allele of Spry1 with a Hoxb7/Cre transgenic line
that expresses cre in the duct but not the mesenchyme
from E9.5 onward (Yu et al., 2002). In situ hybridization
showed that Spry1 expression was absent from the UB
epithelium of Hoxb7/Cre;Spry1flox/flox embryos at E11.5
but was still detectable in the mesenchyme (Figures 4H
and 4I). Spry1 RNA was not detectable in either tissue in
Spry1−/− embryos (Figure 4J). The kidneys of newborn
Hoxb7/Cre;Spry1flox/flox mice were highly disorganized
and exhibited multiple ureters, at a frequency (n = 11/
15; Figure 4G) statistically similar to the kidneys of
Spry1−/− animals (n = 20/21; Figure 2) (p = 0.14, Fisher’sexact test). Therefore, we conclude that Spry1 is re-
quired in the Wolffian duct to regulate kidney induction.
Spry1 Encodes an Antagonist of GDNF/RET
Signaling in the Wolffian Duct
These results suggest a model in which Spry1 regulates
the site of UB outgrowth by antagonizing RET signaling
in the Wolffian duct. To monitor GDNF/RET activity in
the Wolffian duct, we assayed for Wnt11 expression
(Majumdar et al., 2003). Normally, Wnt11 is detected
only in UB tips, where there is a high level of RET acti-
vation (Majumdar et al., 2003). Significantly, in Spry1−/−
embryos, Wnt11 expression extended to more anterior
positions along the Wolffian duct than in Spry1+/− em-
bryos (Figures 5A and 5B). Discrete ectopic sites of
Wnt11 expression were also observed along Spry1−/−
ducts (Figure 5B), presumably reflecting the sites where
the supernumerary UBs form.
Although the mechanism(s) by which Sprouty pro-
teins antagonize RTK signaling are incompletely under-
stood, numerous studies indicate that they antagonize
the RAS/MAPK pathway (Christofori, 2003; Kim and
Bar-Sagi, 2004). If the normal function of SPRY1 in kid-
Developmental Cell
232Figure 2. Kidney and Urogenital Tract Ano-
malies in Spry1−/− Mice
(A–E) Kidneys and urogenital systems from
female (A and B) and male (C–E) Spry1+/−
and Spry1−/− newborn pups are shown. Nor-
mal ureters and abnormal hydroureters are
indicated by red and yellow arrows, respec-
tively. A higher magnification of a hydroure-
ter attached to the vas deferens in a male is
shown (C).
(F) An H&E-stained section of the boxed area
in (C) shows the hydroureter (asterisk) end-
ing in the vas deferens.
(G–I) H&E-stained sections from control (G)
and null (H) kidneys with nephrogenic zones
indicated. Note the epithelial cysts (asterisks
in [H]) that stain strongly with dolichus
biflorus agglutinin (asterisks in [I]).
Abbreviations: Ad, adrenal; Bl, bladder; Ki,
kidney; nz, nephrogenic zone; Te, testis; Ut,
uterus; vas, vas deferens.ney development is to antagonize RAS/MAPK signal- d
Sing, one would expect to detect ectopic sites of MAPK
activity in Spry1−/− Wolffian ducts. To investigate this, e
swe assayed phosphorylated ERK (P-ERK) levels at
~E11 by immunohistochemistry. As suggested by a pre- U
Svious report (Fisher et al., 2001), high levels of P-ERK
were present in the normal ureteric bud (Figure 5C). o
cHowever, in Spry1−/− embryos, additional sites of P-ERK
expression were detected in the ectopic, anterior UBs c
tthat formed along the Wolffian duct (Figure 5D), consis-
tent with the hypothesis that the supernumerary UBs a
rarise as a consequence of enhanced RTK activity.
These observations support the idea that Spry1 pre- m
(vents supernumerary UB formation by antagonizing
GDNF/RET signaling in the posterior Wolffian duct. To e
mprovide a more direct test of this hypothesis, we com-
pared the sensitivity of wild-type and Spry1−/− Wolffian G
rducts to GDNF. Affigel beads were soaked in 0.1–5 ng/
l GDNF and assessed for their ability to induce the u
fformation of supernumerary ureteric buds in wild-type
intermediate mesoderm explant cultures (Sainio et al., t
1997; Tang et al., 2002). Beads soaked in <0.5 ng/l
GDNF were inefficient at inducing ectopic UBs from R
twild-type and Spry1+/− ducts, whereas beads soaked
in GDNF at 0.75 ng/l or higher always induced bud- O
ading (n = 4/4). We reasoned that if the absence of Spry1
rendered cells hypersensitive to GDNF, beads soaked r
din subthreshold concentrations of GDNF should induce
a response in Spry1−/− Wolffian ducts. In accordance o
mwith this prediction, beads soaked in 0.5 ng/l GDNF
readily induced Wnt11 expression in Spry1−/− Wolffian fucts (n = 4/5; Figure 5F), whereas exposure of
pry1+/− ducts to this low concentration of GDNF gen-
rally did not (n = 1/6; Figure 5E). Furthermore, beads
oaked in 0.2 ng/l GDNF elicited outgrowth of multiple
Bs associated with PAX2-positive condensates from
pry1−/− Wolffian ducts (Figure 5H). By contrast, only
ccasional buds with weak or absent PAX2-positive
ondensates were induced in Spry1+/− ducts at this low
oncentration (Figure 5G). The most efficient UB induc-
ion occurred from the posterior Wolffian duct. Whereas
small number of buds were initiated from more ante-
ior positions, no bud formation could be induced from
ost anterior, mesonephric regions of the Wolffian duct
not shown) in agreement with previous studies (Brophy
t al., 2001). This suggests that the competence of the
etanephric versus mesonephric duct to respond to
DNF has not been altered by the loss of Spry1. These
esults strongly support our hypothesis that Spry1 reg-
lates metanephric kidney induction by acting as a
eedback antagonist of GDNF/RET signaling in the pos-
erior Wolffian duct.
educing Gdnf Gene Dosage Rescues
he Spry1−/− Phenotype
ur data suggested that the abnormal UB development
nd supernumerary bud formation in Spry1−/− embryos
esults from elevated sensitivity to GDNF signals. To
efinitively test this idea in vivo, we reduced the level
f GDNF in Spry1−/− embryos by producing animals ho-
ozygous for the Spry1 null allele and heterozygous
or a Gdnf null allele (Sanchez et al., 1996). In only a
SPRY1 Regulates GDNF-Mediated Kidney Induction
233Figure 3. Abnormal Kidney Development in
Spry1−/− Embryos
(A–D) Lateral views of intermediate meso-
derm dissected from or exposed in Spry1
heterozygous and null embryos, hybridized
in whole mount with a probe for Ret RNA.
Brackets indicate the ureteric buds (A and
B). Note the abnormally wide UBs formed
from Spry1−/− Wolffian ducts at E11.0. Ar-
rows point to supernumerary UBs. Arrow-
heads point to the branched tips of the UBs
at E11.5, which are significantly wider in the
mutant embryos (C and D).
(E and F) E11.5 kidney explants cultured in
vitro for 48 hr (equivalent to approximately
E13.5) and stained for cytokeratin in red (ure-
teric tree) and PAX2 in green (condensing
mesenchyme). Arrows indicate supernumer-
ary ureteric trunks.
(G and H) Visualization of Wolffian duct de-
rivatives (collecting ducts and developing
ureters) in whole mount at E14.5 using a
Hoxb7/GFP transgene (Srinivas et al.,
1999a). In normal embryos, a single ureter
from each kidney is joined to the bladder
(white dot in [G] indicates one such connec-
tion). In Spry1 null embryos, supernumerary
ureters (arrows in [H]) are attached to the
Wolffian duct, and dilated ducts (ar-
rowheads) are found between the ureters
and the bladder. Note also the abnormal po-
sition of the testes.
Abbreviations in addition to those used in
Figure 2: HL, hindlimb bud; UB, ureteric bud;
Ur, ureter; Wolffian duct, WD.few of these Spry1−/−;Gdnf+/− animals (4/16) was kidney
development abnormal, whereas most of their Spry1−/−;
Gdnf+/+ littermates (12/13) exhibited ureter and kidney
abnormalities (Figures 5I–5K). Thus, reducing Gdnf dos-
age caused a striking 75% reduction in the incidence
of CAKUT in Spry1 null mice (p = 0.0005, Fisher’s exact
test). These data indicate that hyperresponsiveness of
the Wolffian duct to GDNF is indeed a critical factor
leading to the Spry1 mutant phenotype.
Discussion
Recent studies suggested that the mammalian Sprouty
genes have important roles in development and cancer
by virtue of their ability to inhibit growth factor signaling
(Kim and Bar-Sagi, 2004; Lo et al., 2004). Here, in our
loss-of-function study to define the developmental
function of a mammalian Sprouty gene, we providecompelling evidence that Spry1 functions as a feed-
back antagonist of GDNF/RET signals during early kid-
ney development. In particular, we show that Ret is re-
quired for the maintenance of high levels of Spry1
expression in the Wolffian duct, which in turn serves to
dampen the responsiveness of the duct to GDNF, thus
preventing the formation of supernumerary UBs.
Sprouty Genes Antagonize RTK Signaling Pathways
during Development
Although studies in Drosophila demonstrated that
Sprouty inhibits signaling downstream of a number of
RTKs, most reports to date have focused on the poten-
tial role of vertebrate Sprouty genes as negative regula-
tors of the FGF signaling pathway during development,
partly because the domains of expression of Sprouty
family members are closely associated with sites of
FGF activity during embryogenesis (Chambers and Ma-
Developmental Cell
234Figure 4. Spry1 Gene Expression in the Wolffian Duct Is Regulated by GDNF/RET Signaling, where It Acts to Regulate Kidney Development
(A and B) Ventral views of intermediate mesoderm dissected from Ret+/− and Ret−/− embryos at E11.0, assayed in whole mount for Spry1
expression. Spry1 RNA is abundant in the Wolffian duct and presumptive UB and less abundant in the nephrogenic mesenchyme (NM) of a
normal (Ret+/−) embryo. Spry1 expression is decreased in the Wolffian duct of a Ret−/− embryo.
(C and D) Ventral views of intermediate mesoderm dissected from E11.0 wild-type embryos assayed in whole mount for Spry1 expression
after culture for 2 hr in the absence (C) or presence (D) of GDNF-soaked beads (indicated by arrowheads).
(E and F) Ventral views of E11.0 (40–43 somites) Spry1 heterozygous and null embryos assayed in whole mount for Gdnf expression. The
anterior border of Gdnf expression domain is delineated by the broken line. In both genotypes, this border lies at a level approximately in the
middle of the hindlimb bud.
(G) Kidneys and urogenital tracts from a Hoxb7/Cre;Spry1flox/flox newborn animal. Ectopic renal nodules (asterisks), a hydroureter (yellow
arrow), and an extra ureter attached to the vas deferens (black arrow) are indicated.
(H–J) Lateral views of Spry1flox/flox, Hoxb7/Cre;Spry1flox/flox, and Spry1−/− intermediate mesoderm dissected at E11.5 and assayed for Spry1
expression. In each panel, the tips of the UB branches are indicated. In the normal (Spry1flox/flox) embryo, Spry1 RNA is detected in both the
UB epithelium and the nephrogenic mesenchyme (H). In the Hoxb7/Cre;Spry1flox/flox embryo, Spry1 expression is specifically eliminated from
the UB (I). No Spry1 expression is detected in the Spry1−/− embryo (J).son, 2000; de Maximy et al., 1999; Minowada et al., s
l1999; Zhang et al., 2001). Moreover, overexpression
studies in cell culture consistently demonstrated that t
mSPRY proteins inhibit FGF-mediated signaling (Gross et
al., 2001; Hanafusa et al., 2002; Lim et al., 2000; Sasaki d
tet al., 2001; Yusoff et al., 2002). In addition, overexpres-
sion or misexpression of Sprouty genes during de- t
tvelopment also implied that these genes inhibited FGF
signaling (Chi et al., 2004; Furthauer et al., 2001; Mail- W
Fleux et al., 2001; Minowada et al., 1999; Nutt et al.,
2001; Perl et al., 2003; Tefft et al., 1999). For example, f
pinjection of Xenopus Spry2 or Drosophila spry RNA into
Xenopus oocytes inhibits the convergent extension G
amovements during gastrulation, known to be depen-
dent on FGF signaling (Nutt et al., 2001). While these
studies pointed to a specific role for mammalian S
Ssprouty proteins in FGF-mediated signaling, cell culture
studies showed that Sprouty family members can also T
tinhibit signaling and biological effects induced by
PDGF (Gross et al., 2001), HGF (Lee et al., 2004), VEGF o
e(Impagnatiello et al., 2001; Lee et al., 2001; Sasaki et al.,
2003), and NGF (Gross et al., 2001). Our genetic studies m
Rindicate that Spry1 inhibits the GDNF/RET signaling
pathway during kidney development. Thus, our data tupport the hypothesis that mammalian Sprouty genes,
ike their Drosophila ortholog, encode general RTK an-
agonists that can regulate developmental processes
ediated by a variety of RTK signaling pathways. Our
ata do not rule out a role for Sprouty genes as inhibi-
ors of FGF signaling during kidney development. In
his regard, we note that a recent study demonstrated
hat expression of a human SPRY2 transgene in the
olffian duct affected the response of the duct to both
GFs and GDNF (Chi et al., 2004). Nevertheless, our
inding that reducing Gdnf dosage rescues the Spry1
henotype indicates that an overactive response to
DNF is the critical factor responsible for supernumer-
ry UB formation in Spry1 null embryos.
everal Mechanisms Operate to Prevent
upernumerary Ureteric Bud Formation
he outgrowth of a single UB at a specific site along
he Wolffian duct is imperative for normal kidney organ-
genesis. Gene targeting experiments identified sev-
ral genes that are required to prevent ectopic UB for-
ation. These include Foxc1, Slit2, and its receptor
obo2, which function to restrict Gdnf expression to
he posterior mesenchyme at the onset of kidney de-
SPRY1 Regulates GDNF-Mediated Kidney Induction
235Figure 5. Spry1−/− Wolffian Ducts Are Hypersensitive to GDNF, and Reducing the Gdnf Gene Dosage Rescues the Spry1−/− Phenotype
(A–D) Ventral views of intermediate mesoderm from Spry1 heterozygous and null embryos at ~E11.0.
(A and B) Hybridization in whole mount with a probe for Wnt11 RNA. Expression is detected in the tips of UBs (brackets) and also in ectopic
domains in the anterior Wolffian duct of the null mutant embryo (arrows in B).
(C and D) Immunostaining for active diphosphorylated ERK in the UB (brackets). Note the staining in an ectopic UB in the null mutant embryo
(arrow in D).
(E and F) Affigel beads soaked in 0.5 ng/l GDNF induce Wnt11 expression in E10.5 Spry1−/− (arrows in F) but not in Spry1+/− (E) Wolffian
ducts within 4 hr of culture. Brackets indicate Wnt11 expression in UBs. Beads soaked in BSA alone did not induce ectopic Wnt11 expression
(not shown).
(G and H) Affigel beads soaked in 0.2 ng/l GDNF (dotted circles) induce the formation of supernumerary ureteric buds (asterisks) with
associated PAX2-positive mesenchymal condensates (green) from the Wolffian duct (red) in E10.5 Spry1−/− but not Spry1+/− embryos during
48 hr of culture. The cloacae (Cl) to which the posterior ducts attach are indicated.
(I and J) Newborn Spry1−/−;Gdnf +/+ and Spry1−/−;Gdnf+/− kidneys and urogenital tracts are shown. Extrarenal nodules (asterisks) and hydroure-
ter (arrow) are indicated.
(K) Bar graph showing the number of newborn mice displaying kidney and urinary tract defects (CAKUT). Mice were Spry1 null and either
wild-type or heterozygous for a null allele of Gdnf.velopment, thus preventing activation of RET signaling
at more anterior positions along the Wolffian duct
(Grieshammer et al., 2004; Kume et al., 2000). In con-
trast, loss of Spry1 function does not result in persis-
tence of Gdnf expression in the anterior mesenchyme.
This observation, coupled with our finding that deletion
of Spry1 specifically in the Wolffian duct causes the
same phenotype as is observed in Spry1 null embryos,
supports the hypothesis that Spry1 regulates signaling
downstream of RET by rendering the Wolffian duct less
sensitive to GDNF. In support of this model, we demon-
strate that inactivation of Spry1 results in hypersensitiv-
ity of the Wolffian duct to GDNF protein. These data
indicate that tight control of Gdnf expression alone is
not sufficient to prevent supernumerary UB formation
and that negative feedback regulation of RET activationin the Wolffian duct by Spry1 is critical to ensure normal
kidney induction.
An alternative explanation for our results might be
that loss of Spry1 function causes hyperactivation of
an RTK other than RET, which in turn upregulates Ret
expression, thereby increasing RET signaling and UB
formation. However, this seems unlikely for several
reasons. First, we found no significant difference in Ret
expression at E11 between control and Spry1−/− Wolff-
ian ducts as measured by quantitative PCR (data not
shown). Second, in prior studies, overexpression of Ret
in the Wolffian duct did not lead to ectopic UB forma-
tion unless Ret was mutated to a ligand-independent
form (de Graaff et al., 2001; Srinivas et al., 1999b). These
data are consistent with our conclusion that increased
RET signaling in the absence of SPRY1 causes the for-
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tsearch for genes responsible for human urinary tract
anomalies should include those that encode negative
Eregulators of GDNF/RET activity such as Spry1.
C
A
Signaling Pathways Regulated by SPRY1 t
Gduring Kidney Induction
aThe mechanism by which Sprouty genes exert their ef-
cfects remains controversial (Christofori, 2003; Kim and
s
Bar-Sagi, 2004). In some cultured cells overexpressing i
Sprouty genes, enhanced signaling was reported, chal- w
lenging the notion that Sprouty proteins act only as an- s
ttagonists (Christofori, 2003; Egan et al., 2002; Guy et
al., 2003; Rubin et al., 2003; Tefft et al., 1999). However,
Aour data support a model in which SPRY1 serves as a
T
feedback antagonist of GDNF/RET signaling during re- a
nal organogenesis. o
mNumerous studies have suggested that Sprouty pro-
oteins function by inhibiting the RAS/MAPK pathway.
oOur finding that the ectopic UBs in Spry1−/− embryos
i
contain high levels of P-ERK support the hypothesis S
that SPRY1 affects the RAS/MAPK pathway. However, (
Cit has been reported that GDNF-induced outgrowth of
rectopic UBs from the Wolffian duct could be prevented
oby pharmacological inhibition of the PI3K pathway but
d
not the RAS/MAPK pathway (Tang et al., 2002). More-
over, Xenopus SPRY2 interferes with Ca2+ signaling G
during development (Nutt et al., 2001). Thus, it remains M
(to be determined what signaling pathways downstream
rof RET are responsible for UB formation and which of
dthese are regulated by SPRY1.
S
d
f
Mammalian Sprouty Genes Are Coexpressed A
dduring Kidney Induction
bAt many stages of development, Spry1, Spry2, and
tSpry4 are coexpressed in at least partially overlapping
p
domains (de Maximy et al., 1999; Minowada et al., 1999;
Zhang et al., 2001), raising the possibility that these C
Cgenes are functionally redundant. At the onset of kidney
development, both Spry1 and Spry2 are expressed in
Sthe Wolffian duct (M.A.B., unpublished data). However,
e
mice lacking the Spry2 gene do not exhibit any defects M
in kidney induction (U. Grieshammer, M.A.B., G. Mino- C
Gwada, and G.R.M, unpublished data). Hence, these
SSprouty genes might perform different functions during
nkidney development. Alternatively, they may both con-
M
tribute to the regulation of GDNF/RET signaling, but a
Spry1 activity may be sufficient to support normal kid-
ney development in the absence of Spry2. This type of A
Tfunctional redundancy has been observed for FGF
Tgenes in the developing limb bud: although inactivation
uof Fgf4 has no effect on its own (Moon et al., 2000; Sun
p
et al., 2000) and inactivation of Fgf8 causes only a mild R
limb phenotype (Lewandoski et al., 2000; Moon and Ca- g
pecchi, 2000), inactivation of both genes in the same
Wdomain causes complete failure of limb development
I(Sun et al., 2002). Thus, one might predict an exacerba-
a
tion of the UB phenotype in Spry1;Spry2 double null I
mutants. Such genetic studies may clarify the potential e
(redundancy of Sprouty genes and further elucidate thessential functions of these negative feedback inhibi-
ors in development.
xperimental Procedures
onstruction of the Spry1 Targeting Vector
129/Sv mouse genomic BAC library was screened by PCR, and
wo clones containing the Sprouty1 gene were identified (Incyte
enomics, Palo Alto, CA). An 11.5 kb EcoRI fragment that contains
ll three putative exons, including the third exon that encodes the
omplete open reading frame (ORF), was subcloned into pBlue-
cript. Oligonucleotides containing loxP sequences were inserted
nto BglII sites flanking the ORF. Correct insertion and orientation
ere confirmed by sequencing. A PGKneo cassette flanked by frt
equences was inserted into a unique BclI site 3# of the Spry1 ORF
o generate the targeting construct.
nalysis of Homologous Recombination
he targeting vector, linearized by NotI digestion, was electropor-
ted into R1 ES cells (A. Nagy, Toronto). G418-resistant ES cell col-
nies were isolated and Southern blotting was performed on geno-
ic DNA digested with XbaI or SpeI, using a fragment located 5#
f the sequences in the targeting construct as a probe. Eight out
f a total of 196 clones had undergone homologous recombination,
ndicated by a 7.8 kb fragment in XbaI digests and a 12 kb band in
peI digests. Two clones were injected into C57BL/6 blastocysts
K. Kelley, Mouse Genetics Shared Research Facility, Mount Sinai).
himeric males were mated with C57BL/6J females, and pups de-
ived from the 129/SvJ ES clones were screened for the presence
f the targeted allele by PCR of genomic DNA using the primers
escribed below.
eneration of Mouse Strains and Genotyping by PCR
ice carrying the targeted allele were bred with Flpe deleter mice
Rodriguez et al., 2000) to remove the PGK-neo cassette. Mice car-
ying Spry1flox were crossed with b-Actin/Cre deleter mice (Lewan-
oski et al., 1997) on an FVB/N genetic background to remove the
pry1 ORF and generate a null allele. PCR genotyping confirmed
eletion of the ORF (Figure 1). All subsequent analyses were per-
ormed in this mixed genetic background (129Sv/J; C57BL/6; FVB/N).
nimals carrying a null allele in which the neo cassette was not
eleted were generated by crossing chimeric males directly with
-Actin/Cre females. Animals homozygous for this null allele and
hus on a 129Sv/J; FVB/N genetic background exhibited a kidney
henotype similar to the one described.
The primers used to genotype these animals by PCR were: P1:
TCAATAGGAGTGGACTGTGAAACTGC; P2: GGGAAAACCGTGTT
TAAGGAGTAGC; P3: GTTCTTTGTGGCAGACACTCTTCATTC.
Tissue-specific knockouts were generated by breeding
pry1flox/flox females to males carrying a Hoxb7/Cre transgene (Yu
t al., 2002) and heterozygous for Spry1flox (Hoxb7/Cre;Spry1flox/+).
ice carrying a Gdnf null allele (Sanchez et al., 1996) on a
57BL/6 background were crossed to Spry1+/− animals. Spry1+/−;
dnf+/− animals were intercrossed to produce Spry1−/−;Gdnf+/− and
pry1−/−;Gdnf+/+ newborns, which were analyzed for defects in kid-
ey development. All mouse experiments were approved by the
ount Sinai Institutional Animal Care and Use Committee (USA)
nd the Home Office (UK).
nalysis of Gene Expression by RT-PCR
otal RNA was isolated from fresh tissue using RNA-Stat 60 (Tel-
est Inc., Friendswood, TX). RT-PCR analyses were performed
sing the Promega RT-PCR system. Primers were designed to am-
lify 300 bp fragments from the Spry1 and Spry2 coding regions.
eactions without reverse transcriptase (RT) served as controls for
enomic DNA contamination.
hole-Mount In Situ Hybridization
ntermediate mesoderm from E10.5–E11.5 embryos was isolated
nd fixed overnight in 4% paraformaldehyde in PBS (PFA) at 4°C.
n situ hybridization was carried out using probes for Ret (Srinivas
t al., 1999b), Wnt11 (Majumdar et al., 2003), and Spry1 and Spry2
Minowada et al., 1999). A combination of two probes were used to
SPRY1 Regulates GDNF-Mediated Kidney Induction
237detect Gdnf: one described by Srinivas et al. (1999b) and a shorter
probe provided by U. Grieshammer (UCSF, San Francisco, CA).
Histological Analysis
Newborn mice were sacrificed according to institutional and na-
tional guidelines. Whole kidneys and urogenital tracts were dis-
sected and images captured under a Leica MZAPO microscope
attached to a SONY-DXC970MD digital camera using Scion Image
software. The tissues were fixed for a few hours to overnight in 4%
PFA at 4°C, embedded in paraffin, and 5 m sections were cut and
stained with hematoxylin and eosin (H&E).
Intermediate Mesoderm and Metanephric
Kidney Explant Cultures
Intermediate mesoderm or metanephric kidneys were dissected
from E10.5 or E11.5 embryos, respectively, in ice-cold CO2-inde-
pendent medium (GIBCO) containing 1% fetal bovine serum
(GIBCO). Explants were cultured at 37°C in DMEM (GIBCO) supple-
mented with 290 g/ml glutamine, 100 U/ml penicillin, 100 g/ml
streptomycin, and 10% fetal bovine serum in a 5% CO2, humidified
atmosphere at the medium-air interface on Costar Transwell filters
(0.4 m). For bead experiments, Affigel blue beads (100–200 mesh,
Biorad, Hemel Hempstead, UK) were soaked in recombinant hu-
man GDNF (Promega, Southampton, UK) at the indicated concen-
tration for 1 hr at room temperature, rinsed in PBS, and applied
to the explant culture. After culture, explants were fixed either in
methanol for immunostaining or 4% PFA for in situ hybridization.
For immunostaining, explants were incubated with murine anti-
cytokeratin (Sigma, Surrey, UK) and rabbit anti-PAX2 (Covance,
Cambridge Bioscience, Cambridge, UK) antibodies, followed by
Alexa488 anti-mouse Ig and Alexa546 anti-rabbit Ig (Molecular
Probes, Invitrogen, Paisley, UK). Staining for P-ERK was performed
as described (Corson et al., 2003). Images were captured on a
Zeiss axioskop microscope attached to a Colorview12 digital
camera.
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